These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10443960)

  • 1. Hyperhomocysteinemia and thrombosis.
    Guba SC; Fonseca V; Fink LM
    Semin Thromb Hemost; 1999; 25(3):291-309. PubMed ID: 10443960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia, atherosclerosis and thrombosis.
    Cattaneo M
    Thromb Haemost; 1999 Feb; 81(2):165-76. PubMed ID: 10063987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients.
    Refai TM; Al-Salem IH; Nkansa-Dwamena D; Al-Salem MH
    Clin Rheumatol; 2002 Nov; 21(6):457-61. PubMed ID: 12447627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced risk of thrombotic disease in patients with acquired vitamin B12 and/or folate deficiency: role of hyperhomocysteinemia.
    Remacha AF; Souto JC; Rámila E; Perea G; Sarda MP; Fontcuberta J
    Ann Hematol; 2002 Nov; 81(11):616-21. PubMed ID: 12454698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine and arterial occlusive disease: a concise review.
    Andreotti F; Burzotta F; Mazza A; Manzoli A; Robinson K; Maseri A
    Cardiologia; 1999 Apr; 44(4):341-5. PubMed ID: 10371785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine in vascular Behcet disease: a meta-analysis.
    La Regina M; Orlandini F; Prisco D; Dentali F
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2067-74. PubMed ID: 20634474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of homocysteine, vitamin B12, folic acid, and MTHFR C677T in patients with a thrombotic event or recurrent fetal loss.
    Nadir Y; Hoffman R; Brenner B
    Ann Hematol; 2007 Jan; 86(1):35-40. PubMed ID: 17043779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine and risk for atherothrombotic events.
    Puddu P
    Cardiologia; 1999 Jul; 44(7):627-31. PubMed ID: 10476587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis.
    Hoţoleanu C; Porojan-Iuga M; Rusu ML; Andercou A
    Rom J Intern Med; 2007; 45(2):159-64. PubMed ID: 18333369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Homocysteine. The cardiovascular risk factor of the next millennium?].
    Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
    An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis].
    Wuillemin WA; Solenthaler M
    Vasa; 1999 Aug; 28(3):151-5. PubMed ID: 10483317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
    Trimarchi H; Young P; Díaz ML; Schropp J; Forrester M; Freixas E
    Medicina (B Aires); 2005; 65(6):513-7. PubMed ID: 16433478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retinal vein occlusion and hyperhomocysteinemia].
    Blondel J; Glacet-Bernard A; Bayani N; Blacher J; Lelong F; Nordmann JP; Coscas G; Soubrane G
    J Fr Ophtalmol; 2003 Mar; 26(3):249-53. PubMed ID: 12746600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperhomocysteinemia: atherothrombosis and neurotoxicity].
    Fridman O
    Acta Physiol Pharmacol Ther Latinoam; 1999; 49(1):21-30. PubMed ID: 10797837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance.
    Boers GH
    Thromb Haemost; 1997 Jul; 78(1):520-2. PubMed ID: 9198207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine and thrombosis: from basic science to clinical evidence.
    Undas A; Brozek J; Szczeklik A
    Thromb Haemost; 2005 Nov; 94(5):907-15. PubMed ID: 16363230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aetiology and treatment of hyperhomocysteinaemia causing ischaemic stroke.
    Sarkar PK; Lambert LA
    Int J Clin Pract; 2001 May; 55(4):262-8. PubMed ID: 11406912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms.
    Zhou J; Austin RC
    Biofactors; 2009; 35(2):120-9. PubMed ID: 19449439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.